Your browser doesn't support javascript.
loading
Perioperative factors associated with survival following surgery for pancreatic cancer - a nationwide analysis of 473 cases from Denmark.
Spore, Laura Marr; Dencker, Emilie Even; Kvanner, Eske Aasvang; Hansen, Carsten Palnaes; Burgdorf, Stefan Kobbelgaard; Krohn, Paul Suno; Kollbeck, Sophie Louise Gisela; Storkholm, Jan Henrik; Sillesen, Martin.
Affiliation
  • Spore LM; Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Dencker EE; Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Kvanner EA; Department of Anesthesia, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Hansen CP; Institute of Clinical Medicine, University of Copenhagen Medical School, Copenhagen, Denmark.
  • Burgdorf SK; Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Krohn PS; Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Kollbeck SLG; Institute of Clinical Medicine, University of Copenhagen Medical School, Copenhagen, Denmark.
  • Storkholm JH; Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Denmark.
  • Sillesen M; Department of Organ Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Denmark.
BMC Surg ; 24(1): 76, 2024 Mar 02.
Article in En | MEDLINE | ID: mdl-38431571
ABSTRACT

BACKGROUND:

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers worldwide, with an overall 5-year survival rate of only 5%. The effect of perioperative treatment factors including duration of surgery, blood transfusions as well as choice of anesthesia and analgesia techniques on overall survival (OS) following pancreatic resections for PDAC, is currently not well known. We hypothesized that these perioperative factors might be associated with OS after pancreatic resections for PDAC.

METHODS:

This is a retrospective study from a nationwide cohort of patients who underwent surgery for PDAC in Denmark from 2011 to 2020. Kaplan-Meier 1, 2 and 5-year survival estimates were 73%, 49% and 22%, respectively. Data were obtained by joining the national Danish Pancreatic Cancer Database (DPCD) and the Danish Anaesthesia Database (DAD). Associations between the primary endpoint (OS) and perioperative factors including duration of surgery, type of anesthesia (intravenous, inhalation or mixed), use of epidural analgesia and perioperative blood transfusions were assessed using Hazard Ratios (HRs). These were calculated by Cox regression, controlling for relevant confounders identified through an assessment of the current literature. These included demographics, comorbidities, perioperative information, pre and postoperative chemotherapy, tumor staging and free resection margins.

RESULTS:

Overall, data from 473 resected PDAC patients were available. Multivariate Cox regression indicated that perioperative blood transfusions were associated with shorter OS (HR 2.53, p = 0.005), with survival estimates of 8.8% in transfused vs. 28.0% in non-transfused patients at 72 months after surgery. No statistically significant associations were identified for the duration of surgery or anesthesia/analgesia techniques.

CONCLUSION:

In this study, the use of perioperative blood transfusions was associated with shorter OS.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Limits: Humans Country/Region as subject: Europa Language: En Journal: BMC Surg Year: 2024 Document type: Article Affiliation country: Denmark

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Carcinoma, Pancreatic Ductal Limits: Humans Country/Region as subject: Europa Language: En Journal: BMC Surg Year: 2024 Document type: Article Affiliation country: Denmark